Indeed, in KTRs, crosstalk between kidney, arteries and bone via molecules and signaling pathways play a role in the development of CKD–MBD [5, 6] and sclerostin is one of these of molecules. This evidence concerns the gene SOST and Marchiafava-Bignami disease.